International Biotechnology Trust’s Alkermes ALKS Stock Holding History

International Biotechnology Trust’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-593,000	Closed	-$16.7M	–	63
2023 Q1	$16.7M	Hold	593,000	–	–	4.66%	5
2022 Q4	$15.5M	Hold	593,000	–	–	4.78%	4
2022 Q3	$13.2M	Buy	593,000 +591,481	+38,939%	+$15.4M	4.25%	4
2022 Q2	$51K	Buy	+1,519	New	+$43.6K	0.53%	41
2021 Q3	–	Sell	-45,000	Closed	-$1.1M	–	69
2021 Q2	$1.1M	Buy	+45,000	New	+$1M	0.29%	51
2020 Q2	–	Sell	-52,000	Closed	-$749K	–	54
2020 Q1	$749K	Buy	+52,000	New	+$928K	0.34%	40
2019 Q3	–	Sell	-70,000	Closed	-$1.58M	–	59
2019 Q2	$1.58M	Sell	70,000 -163,000	-70%	-$4.47M	0.59%	42
2019 Q1	$8.5M	Buy	+233,000	New	+$7.69M	3.14%	10

Other funds holding ALKS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HJGA

Hardman Johnston Global Advisors Stamford, Connecticut $2.85B AUM 35.77% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

International Biotechnology Trust's ALKS Position: Q2 2023 in Review

International Biotechnology Trust sold out of Alkermes (ALKS) in Q2 2023, closing a stake of 593,000 shares — an estimated $16.7M sold.

International Biotechnology Trust first reported a position in ALKS in Q1 2019 and held it in 8 quarters. The position peaked at $16.7M in Q1 2023. 292 funds tracked by Wall St. Rank hold ALKS as of Q2 2023.

International Biotechnology Trust reported no remaining Alkermes position as of Q2 2023 after selling out during the quarter.
International Biotechnology Trust sold 593,000 Alkermes shares in Q2 2023, an estimated $16.7M.
International Biotechnology Trust first reported a position in Alkermes in Q1 2019 and held it in 8 quarters.
International Biotechnology Trust's Alkermes position peaked at $16.7M in Q1 2023.
292 funds tracked by Wall St. Rank held Alkermes as of Q2 2023.

Based on International Biotechnology Trust's 13F filing for Q2 2023, filed 8 Aug 2023.